.JPG?ad=18503&adview=true)
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Tumor Biology |
Departments of Medical Biophysics [G. N. N., I. C. M., K. V. N., V. L. M., A. C. G., A. F. C.], Microbiology and Immunology [V. L. M.], and Oncology [V. L. M., A. F. C.], University of Western Ontario, London, Ontario, N6A 5C1 Canada, and London Regional Cancer Centre, London, Ontario, N6A 4L6 Canada [G. N. N., P. M. W., N. K., S. M. W., A. F. C.]
Tumors can recur years after treatment, and breast cancer is especially noted for long periods of dormancy. The status of the cancer during this period is poorly understood. As a model to study mechanisms of dormancy, we used murine D2.0R mammary carcinoma cells, which are poorly metastatic but form occasional metastases in liver and other organs after long latency. Highly metastatic D2A1 cells provided a positive, metastatic control. Our goals were to learn how the cell lines differ in survival kinetics in a secondary site and to seek evidence for the source of D2.0R dormancy. In spontaneous metastasis assays from mammary fat pad injections, we found evidence for dormancy because of a persistence of large numbers of solitary cells in the liver. To quantify the fate of cells after arrival in liver, experimental metastasis assays were used. To permit identification of cells that had not divided, cells were labeled before injection with fluorescent nanospheres, which were diluted to undetectable levels by cell division. Cancer cells were injected i.v. to target them to the liver and coinjected with reference microspheres to monitor cell survival. Dormancy was defined as retention of nanosphere fluorescence in vivo, as well as negative staining for the proliferation marker Ki67. A large proportion of D2.0R cells persisted as solitary dormant cells. No metastases formed, but viable cells could be recovered from the liver 11 weeks after injection. Large numbers of solitary, dormant, Ki67-negative D2A1 cells were also detected against a background of progressively growing metastases. Thus, this study identified a possible contributor to tumor dormancy: solitary, dormant cells that persist in tissue. If such cells are present in patients, they could contribute to tumor recurrence and would not be susceptible to current therapeutic strategies targeting proliferating cells.
This article has been cited by other articles:
|
|
 |
|
  W. Yang, D. Luo, S. Wang, R. Wang, R. Chen, Y. Liu, T. Zhu, X. Ma, R. Liu, G. Xu, et al. TMTP1, a Novel Tumor-Homing Peptide Specifically Targeting Metastasis Clin. Cancer Res., September 1, 2008; 14(17): 5494 - 5502. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Barkan, H. Kleinman, J. L. Simmons, H. Asmussen, A. K. Kamaraju, M. J. Hoenorhoff, Z.-y. Liu, S. V. Costes, E. H. Cho, S. Lockett, et al. Inhibition of Metastatic Outgrowth from Single Dormant Tumor Cells by Targeting the Cytoskeleton Cancer Res., August 1, 2008; 68(15): 6241 - 6250. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Demicheli, M. W. Retsky, W. J. M. Hrushesky, M. Baum, and I. D. Gukas The effects of surgery on tumor growth: a century of investigations Ann. Onc., June 10, 2008; (2008) mdn386v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A Vincent-Salomon, F C Bidard, and J Y Pierga Bone marrow micrometastasis in breast cancer: review of detection methods, prognostic impact and biological issues J. Clin. Pathol., May 1, 2008; 61(5): 570 - 576. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. W. Moon, H.-C. Jeung, S. Y. Rha, N. C. Yoo, J. K. Roh, S. H. Noh, B. S. Kim, and H. C. Chung Changing Patterns of Prognosticators During 15-Year Follow-Up of Advanced Gastric Cancer after Radical Gastrectomy and Adjuvant Chemotherapy: A 15-Year Follow-Up Study at a Single Korean Institute Ann. Surg. Oncol., October 1, 2007; 14(10): 2730 - 2737. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Xenidis, V. Markos, S. Apostolaki, M. Perraki, A. Pallis, G. Sfakiotaki, D. Papadatos-Pastos, L. Kalmanti, M. Kafousi, E. Stathopoulos, et al. Clinical relevance of circulating CK-19 mRNA-positive cells detected during the adjuvant tamoxifen treatment in patients with early breast cancer Ann. Onc., October 1, 2007; 18(10): 1623 - 1631. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Cady Regional Lymph Node Metastases; a Singular Manifestation of the Process of Clinical Metastases in Cancer: Contemporary Animal Research and Clinical Reports Suggest Unifying Concepts Ann. Surg. Oncol., June 1, 2007; 14(6): 1790 - 1800. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. R. Langley and I. J. Fidler Tumor Cell-Organ Microenvironment Interactions in the Pathogenesis of Cancer Metastasis Endocr. Rev., May 1, 2007; 28(3): 297 - 321. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Demicheli, W. J. M. Hrushesky, M. W. Retsky, G. Bonadonna, and P. Valagussa Letter to the Editor Ann. Surg. Oncol., April 1, 2007; 14(4): 1519 - 1520. [Full Text] [PDF]
|
|
|
|
 |
|
 M. Suzuki, E. S. Mose, V. Montel, and D. Tarin Dormant Cancer Cells Retrieved from Metastasis-Free Organs Regain Tumorigenic and Metastatic Potency Am. J. Pathol., August 1, 2006; 169(2): 673 - 681. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Spangenberg, E. U. Lausch, T. M. Trost, D. Prawitt, A. May, R. Keppler, S. A. Fees, D. Reutzel, C. Bell, S. Schmitt, et al. ERBB2-Mediated Transcriptional Up-regulation of the {alpha}5{beta}1 Integrin Fibronectin Receptor Promotes Tumor Cell Survival Under Adverse Conditions. Cancer Res., April 1, 2006; 66(7): 3715 - 3725. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Demicheli, R. Miceli, A. Moliterni, M. Zambetti, W. J. M. Hrushesky, M. W. Retsky, P. Valagussa, and G. Bonadonna Breast cancer recurrence dynamics following adjuvant CMF is consistent with tumor dormancy and mastectomy-driven acceleration of the metastatic process Ann. Onc., September 1, 2005; 16(9): 1449 - 1457. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. L. Collins, M. J. Reginato, J. K. Paulus, D. C. Sgroi, J. LaBaer, and J. S. Brugge G1/S Cell Cycle Arrest Provides Anoikis Resistance through Erk-Mediated Bim Suppression Mol. Cell. Biol., June 15, 2005; 25(12): 5282 - 5291. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. J. Strewler Awakened From Sleep: Dormancy in Stem Cells and Bone Metastases IBMS BoneKEy, December 1, 2004; 1(12): 3 - 5. [Full Text] [PDF]
|
|
|
|
|
|
J. A. Aguirre-Ghiso, L. Ossowski, and S. K. Rosenbaum Green Fluorescent Protein Tagging of Extracellular Signal-Regulated Kinase and p38 Pathways Reveals Novel Dynamics of Pathway Activation during Primary and Metastatic Growth Cancer Res., October 15, 2004; 64(20): 7336 - 7345. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Goodison, K. Kawai, J. Hihara, P. Jiang, M. Yang, V. Urquidi, R. M. Hoffman, and D. Tarin Prolonged Dormancy and Site-specific Growth Potential of Cancer Cells Spontaneously Disseminated from Nonmetastatic Breast Tumors as Revealed by Labeling with Green Fluorescent Protein Clin. Cancer Res., September 1, 2003; 9(10): 3808 - 3814. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. S. Zeelenberg, L. Ruuls-Van Stalle, and E. Roos The Chemokine Receptor CXCR4 Is Required for Outgrowth of Colon Carcinoma Micrometastases Cancer Res., July 1, 2003; 63(13): 3833 - 3839. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. R. Welch and K. W. Hunter A New Member of the Growing Family of Metastasis Suppressors Identified in Prostate Cancer J Natl Cancer Inst, June 18, 2003; 95(12): 839 - 841. [Full Text] [PDF]
|
|
|
|
 |
|
 K. A. Lawson, K. Anderson, M. Menchaca, J. Atkinson, L. Sun, V. Knight, B. E. Gilbert, C. Conti, B. G. Sanders, and K. Kline Novel Vitamin E Analogue Decreases Syngeneic Mouse Mammary Tumor Burden and Reduces Lung Metastasis Mol. Cancer Ther., May 1, 2003; 2(5): 437 - 444. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Seki, Y. Hayakawa, A. D. Brooks, J. Wine, R. H. Wiltrout, H. Yagita, J. E. Tanner, M. J. Smyth, and T. J. Sayers Tumor Necrosis Factor-related Apoptosis-inducing Ligand-mediated Apoptosis Is an Important Endogenous Mechanism for Resistance to Liver Metastases in Murine Renal Cancer Cancer Res., January 1, 2003; 63(1): 207 - 213. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Ahmed, J. Wyckoff, E. Y. Lin, W. Wang, Y. Wang, L. Hennighausen, J.-i. Miyazaki, J. Jones, J. W. Pollard, J. S. Condeelis, et al. GFP Expression in the Mammary Gland for Imaging of Mammary Tumor Cells in Transgenic Mice Cancer Res., December 15, 2002; 62(24): 7166 - 7169. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
